Plasma Aldosterone Is Related to Severity of Obstructive Sleep Apnea in Subjects With Resistant Hypertension
Authors:
- Mari K. NishizakaMNMari K. Nishizaka
- Robyn L. BoedefeldRBRobyn L. Boedefeld
- Stacey S. CofieldSCStacey S. Cofield
- Susan M. HardingSHSusan M. Harding
- David A. CalhounDCDavid A. Calhoun
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Renal Damage in Primary AldosteronismHypertension, 2006
- Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sampleKidney International, 2006
- Value of Noninvasive Hemodynamics to Achieve Blood Pressure Control in Hypertensive SubjectsHypertension, 2006
- Long-term Effects of Nasal Continuous Positive Airway Pressure Therapy on Cardiovascular Outcomes in Sleep Apnea SyndromeChest, 2005
- Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational studyThe Lancet, 2005
- Effect of Nasal Continuous Positive Airway Pressure Treatment on Blood Pressure in Patients With Obstructive Sleep ApneaCirculation, 2003
- Resistant HypertensionHypertension, 2002
- Effect of nasal CPAP treatment on plasma volume, aldosterone and 24‐h blood pressure in obstructive sleep apnoeaJournal of Sleep Research, 1996
- Regulation of plasma volume during obstructive sleep apnoeaJournal of Sleep Research, 1995
- Clinical implications of primary aldosteronism with resistant hypertension.Hypertension, 1988